DOI:

"I did not see it coming"... the hard way for the prevention of complications

Eric Eeckhout1, MD, PhD; Amir Lerman2*, MD

“The only person who does not fall from the horse is the one that does not ride.” Based on this principle it is obvious that “the only person who does have any complications is the person who does not perform any or enough procedures”.

The majority of complications in the field of interventional cardiology result from our decision making process and from the underestimation of the downstream effect of our decisions. Based on these principles, the presentations and the discussion of our own errors should lead to an improvement of our safety record and to better patients’ care. The following papers that you will see in the “Focus” section of this issue of EuroIntervention are the fruit of labour of several years of international meetings on “Complications during PCI” organised by our cardiology department since 1998 at the University Hospital of Lausanne. Since 2001, this congress has become a joint event, co-organised with the department of cardiovascular diseases of the Mayo Clinic in Rochester, MN, USA. To celebrate our 10 year anniversary, a two days expert meeting was organised in Lausanne addressing practical recommendations for the prevention of complication during PCI. Endorsed by the European Association for Percutaneous Cardiovascular Interventions (EAPCI) and its official journal (EuroIntervention), the results of this effort are now being published here. Several areas of interest were identified and discussed engaging a group of 20 experts divided into working groups based on these topics. A short overview of each subject can be found below as well as the key elements of each paper in the journal. The full papers, as well as an extensive literature review is available on line on the journal’s website.

Group 1

DEALING WITH MAJOR COMPLICATIONS (CORONARY PERFORATION AND NO REFLOW)

An algorithm for the treatment of no-reflow and perforation was proposed and treatment alternatives were discussed. The consensus was to propose adenosine as a first line drug for the improvement of the no-flow phenomenon. Coronary perforation, although a very rare complication, carries high rates of the morbidity and mortality. Clinical predictors of coronary perforations were identified such the elderly, female gender, tortuous, calcified and small arteries. Furthermore, procedural predictors such as rotational atherectomy, the use of particular guidewires (stiff & hydrophilic wires), balloons oversizing (ratio artery to balloon of >1.2-1.3) and balloon rupture (by a jet effect) were identified.

The group proposed algorithms for the identification and treatment of these complications.

Group 2

RATIONALE USE OF ANTIPLATELET AND ANTITHROMBOTIC DRUGS DURING PCI

With respect to cardiovascular interventions, the combination of both anticoagulant and antiplatelet therapies is mandatory to prevent thrombosis because activation of both platelets and the coagulation system contribute to thrombus formation in the setting of PCI. The choice, initiation and duration of antithrombotic strategies are based on the clinical setting (elective, acute or urgent intervention). To optimise the efficacy of a given therapy and to reduce the potential bleeding hazard both, ischaemic and bleeding risks have to be evaluated on an individual basis.

Group 3

RADIATION SAFETY DURING CARDIOVASCULAR INTERVENTIONS

This group discussed the optimal methodology to reduce radiation exposure and the need for better monitoring of radiation throughout the procedure.

Group 4

PREVENTING COMPLICATIONS: A CHECKLIST

There is a growing interest in developing a checklist for medical procedures. This concept originated from the aviation industry, which is considered one of the safest industries today. The importance of creating this checklist for interventional procedure is underscored by a recent report issued by the World Health Organisation. The initial guidelines aim at reducing complications and deaths from the rising numbers of operations now being performed. Some steps in this proposed checklist might seem trivial or just simply logical. However, not following these steps can lead to complications. A physical checklist might prevent “cutting corners” or other problems related to misunderstanding or miscommunication between members of the PCI team. As we already mentioned, this checklist is not a “cookbook” list at all, but should be concretized by each individual institution according to its own policy and legislation.

The following manuscripts will provide a pathway for the prevention of complications based on the integration of evidence based medicine, guidelines and mainly personal experience along with common sense.

Volume 4 Number 2
Aug 20, 2008
Volume 4 Number 2
View full issue


Key metrics

Suggested by Cory

Editorial

10.4244/EIJ-D-26-00479 Jun 1, 2026
Valve thrombosis or valve deterioration: what truly drives the prognosis?
Waksman R and Phichaphop A
free

State-of-the-Art

10.4244/EIJ-D-25-00874 Jun 1, 2026
TAVI and coronary interventions: indications, technical considerations, and clinical scenarios
Aquino Bruno H et al
free

Original Research

10.4244/EIJ-D-25-01370 Jun 1, 2026
Prognostic value of early haemodynamic valve deterioration after TAVI
Trimaille A et al

Original Research

10.4244/EIJ-D-25-01268 Jun 1, 2026
Early outcomes of redo-TAVI with the SAPIEN 3 platform: the prospective, multicentre ReTAVI registry
Tarantini G et al

Research Correspondence

10.4244/EIJ-D-25-01160 Jun 1, 2026
First-in-human experience with a heterotopic cross-caval transcatheter tricuspid valve replacement
Estevez-Loureiro R et al

Original Research

10.4244/EIJ-D-26-00416 May 21, 2026
Long-term clinical outcomes of high-risk plaques with negative fractional flow reserve: the PECTUS-obs study
Volleberg R et al
Trending articles
202.75

State-of-the-Art

10.4244/EIJ-D-21-00089 Jun 11, 2021
Intracoronary optical coherence tomography: state of the art and future directions
Ali ZA et al
free
87.2

State-of-the-Art

10.4244/EIJ-D-25-00266 Jan 19, 2026
Lesion stratification with intracoronary imaging
McGarvey M et al
free
47.45

NEW INNOVATION

10.4244/EIJ-D-15-00467 Feb 20, 2018
Design and principle of operation of the HeartMate PHP (percutaneous heart pump)
Van Mieghem NM et al
free
34.8

Original Research

10.4244/EIJ-D-25-01006 Mar 16, 2026
Clinical outcomes and haemodynamic response after blinded stress assessment of moderate aortic stenosis
Eerdekens R et al
23.15

Original Research

10.4244/EIJ-D-25-01370 May 21, 2026
Prognostic value of early haemodynamic valve deterioration after TAVI
Trimaille A et al
23.15

Original Research

10.4244/EIJ-D-25-01370 Jun 1, 2026
Prognostic value of early haemodynamic valve deterioration after TAVI
Trimaille A et al
22.35

State-of-the-Art

10.4244/EIJ-D-25-00874 Jun 1, 2026
TAVI and coronary interventions: indications, technical considerations, and clinical scenarios
Aquino Bruno H et al
free
22.2

Viewpoint

10.4244/EIJ-D-25-01066 May 4, 2026
Intracoronary imaging guidance for de novo coronary lesion treatment with drug-coated balloons
Amabile N et al
free
20.75

Flashlight

10.4244/EIJ-D-25-01014 Apr 6, 2026
Stent retriever-assisted coronary thrombectomy with continuous aspiration
Liabot Q et al
open access
X

PCR
Impact factor: 9.5
2024 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2025)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2026 Europa Group - All rights reserved